Vikasith delivers end-to-end CDMO solutions — from early-stage development (Pre-IND) to commercial API manufacturing. Our integrated capabilities include process development, optimization, analytical testing, and regulatory support, ensuring seamless progress through every phase of your molecule’s lifecycle.
Build the Future of Healthcare with Vikasith
![]()
Comprehensive CDMO Services
Vikasith offers a complete spectrum of contract development and manufacturing services (CDMO) for the biotechnology and pharmaceutical sectors. From early-stage drug development (Pre-IND) through commercial production, we deliver customized, end-to-end solutions tailored to your molecule’s unique requirements. Our expertise spans process development, scale-up optimization, analytical characterization, quality assurance, and regulatory documentation — ensuring your molecule progresses efficiently and compliantly through every development milestone.
Our CDMO Capabilities
Manufacturing Capabilities
Multiple production units ~ 1824 KL installed capacity Strong & competent.
Regulatory Approvals
Manufacturing units approved by all major regulatory bodies including USFDA, EDQM, PMDA,KFDA, COFEPRIS, ANVISA
Financial Position
A debt free company DUNS & BRADSTREET Rating – 5A2
A Strong CDMO Partner
Successful & timely completion and supply of Project Orchid J&J products is a testimonial to our commitment and capability to deliver quality products
Additional Capacity
At VPCL Unit-5, 764KL of available manufacturing capacity and future expansion of 175 KL(Intermediates & API) Flexible to provide any modification in facility on customer request
Corporate Social Responsibility
CSR has been a core value since 2002, a decade before it became mandatory by an act of parliament 1/3rd of Wealth of Vasudha has been allocated for CSR activities by the founder
Environment, Health & Safety
Integrating sustainability into every aspect of perations, emphasizing environmental stewardship, economic growth, and social responsibility. Always ready to follow the guidance provided by our MNC partners
